TRex Bio Inc. (TRXB)
NASDAQ: TRXBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 12, 4:00 PM ET · Delayed 15 min
After hours: 13.99 -0.29%
TRXB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $385.06M
- EPS (TTM)
- -$2.47
- Dividend yield
- None
- 52-week range
- 13.50 – 15.50
- Day range
- 13.75 – 14.36
- Volume / Avg
- 188.96K / 1.26M
- Beta
- —
- Shares outstanding
- 27.45M
52-week range
TRXB stock today
On Oct 12, TRXB ended the session at $14.03, adding $0.03 (0.21%), versus the S&P 500's 0.06% decline. Trading was light, with 188.96K shares changing hands, about 15% of the average daily volume. At this level, TRXB sits in the middle of its 52-week range of $13.50 to $15.50: 9.5% below the high and 3.9% above the low.
TRex Bio has posted a net loss over the last twelve months (EPS of -$2.47), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About TRex Bio
Company profileTRex Bio, Inc. operates as a clinical-stage biopharmaceutical company that engages in discovery and development of immunoregulatory medicines. It develops medicines that helps restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Employees
- 60
- IPO year
- 2026
- Website
- trex.bio
TRex Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KYTXKyverna Therapeutics Inc. | 6.21 | -2.82% | $384.05M | vs TRXB |
| ZURAZura Bio Limited Class A | 4.00 | 0.00% | $383.32M | vs TRXB |
| SCTXScribe Therapeutics Inc. | 20.67 | -2.36% | $391.32M | vs TRXB |
| CCCCC4 Therapeutics Inc. | 3.06 | -3.16% | $376.46M | vs TRXB |
| FENCFennec Pharmaceuticals Inc. | 10.72 | +0.09% | $375.92M | vs TRXB |
| EIKNEikon Therapeutics Inc. | 7.26 | -2.81% | $393.24M | vs TRXB |
| EDITEditas Medicine Inc. | 2.75 | -5.17% | $422.35M | vs TRXB |
| AGENAgenus Inc. | 7.43 | -3.13% | $335.55M | vs TRXB |
Indexes, lists and sector
TRex Bio stock FAQ
What is TRex Bio's stock price today?
TRXB last traded at $14.03 as of Oct 12, 4:00 PM EDT, up 0.21% on the day. Prices are delayed at least 15 minutes.
What is the TRXB 52-week high?
The 52-week high for TRXB is $15.50 and the 52-week low is $13.50. The stock is currently 9.5% below its high.